Parfum/Extrait de Parfum: At 25 to 40% fragrance concentrate, these are deep, rich, and designed to last all day with just a ...
Neuphoria Therapeutics (NEUP) announced that the AFFIRM-1 Phase 3 trial of BNC210 for the acute treatment of social anxiety disorder did not meet ...
Parfum/Extrait de Parfum: At 25 to 40% fragrance concentrate, these are deep, rich, and designed to last all day with just a dab. Eau de Parfum: The most popular strength for its staying power (around ...
AFFIRM-1 trial did not meet primary endpoint or secondary endpointsCompany to conduct strategic review of portfolio and business ...